Flagship Founder and CEO Noubar Afeyan was joined by Aviv Regev, Executive Vice President at Genentech Research and Early Development (gRED) for a fascinating discussion on the intersection of AI and biology, the future of R&D, and the leaps in store for biomedicine. More from Flagship @ JPM2023 here.
More from:
Human Health
What If We Could See Disease Coming and Stop It?
Amanda Kay on a New Approach to Biopharma Partnerships
Pioneering Partnerships: Advancing a Portfolio of Novel Medicines and Vaccines with GSK
Pioneering Partnerships: Accelerating our Collaboration with Pfizer
Unlocking Therapeutic Breakthroughs with the Power of Platform Technologies
